Managing the dose escalation of biologics in an era of cost containment: the need for a rational strategy
Although biologic medications have demonstrated great efficacy for the treatment of psoriasis, a subset of patients fails to respond and others lose response later in the course.In treating a patient who has hbl5266ca failed to respond to biologic therapy, clinicians must decide between dose escalation, switching biologics, and adding or switching